You have been logged out of VisualDx or your session has expired.

Please reload this page and sign into VisualDx to continue.

..
  VisualDx Mobile   Select Language

Get VisualDx Mobile

There are VisualDx mobile apps available for iOS and Android devices.

You will need a VisualDx account to use the mobile apps.



Already have an account? Sign In or
sign up for a free trial.

Users with VisualDx accounts earn CME credits for using VisualDx.

Already have an account? Sign In or
sign up for a free trial.

Create a Personal Account

E-mail (username)
Password
Verify Password
First Name
Last Name

Personal Account Created

Mobile Access

You can now download VisualDx for your iOS and Android devices. Launch the VisualDx app from your device and sign in using your VisualDx personal account username and password.

CME Certification

Sign in with your personal account to earn and claim CME credits through VisualDx. Credits can be earned by building a differential or looking up a diagnosis.

Version: 7.13.1441   (build df7aed4)
Select Language


Select Region

Send us your feedback

E-mail
Message
This field is required

Oops! There was an issue during submission. Please try again. If the problem persists, email feedback@visualdx.com with your feedback.

Thank You!

We appreciate your feedback and you will be hearing from us soon.

OK

Share This Page

Thank You!

We have sent an e-mail with a link to the current page.

OK

E-mail This Patient Information Sheet

Thank You!

We have sent an e-mail with this patient information.

OK

Image Contributors

Individuals

  • Christine Ahn MD
    Carl Allen DDS, MSD
    Brandon Ayres MD
    Howard P. Baden MD
    Robert Baran MD
    Keira Barr MD
    Gregory J. Basura MD, Ph.D
    Donald Belsito MD
    Jeffrey D. Bernhard MD
    Jesse Berry MD
    Victor Blanco MD
    Benjamin R. Bohaty MD
    William Bonnez MD
    Sarah Brenner MD
    Robert A. Briggaman MD
    Robert Brodell MD
    Roman Bronfenbrener MD
    Walter Brooks MD
    William Buckley MD
    Philip Bulterys MD, PhD (candidate)
    Susan Burgin MD
    Sonya Burton MD
    Sean P. Bush MD, FACEP
    Jeffrey Callen MD
    Scott Camazine MD
    Michael Cardwell
    Shelley D. Cathcart MD
    Robert Chalmers MD, MRCP, FRCP
    Chia-Yu Chu MD, PhD
    Flavio Ciferri MD
    Maria Rosa Cordisco MD
    Noah Craft MD, PhD
    John T. Crissey MD
    Harold E. Cross MD, PhD
    Charles E. Crutchfield III MD
    Adriana Cruz MD
    Donna Culton MD, PhD
    Bart J. Currie MBBS, FRACP, DTM&H
    Chicky Dadlani MD
    Alexander Dane DO
    C. Ralph Daniel III MD
    Thomas Darling MD, PhD
    William Delaney MD
    Damian P. DiCostanzo MD
    Ncoza Dlova MD
    James Earls MD
    Libby Edwards MD
    Melissa K. Egge MD
    Charles N. Ellis MD
    Rachel Ellis MD
    David Elpern MD
    Nancy Esterly MD
    Stephen Estes MD
    E. Dale Everett MD
    Janet Fairley MD
    David Feingold MD
    Jennifer J. Findeis-Hosey MD
    Benjamin Fisher MD
    Henry Foong MBBS, FRCP
    David Foster MD, MPH
    Brian D. Foy PhD
    Michael Franzblau MD
    Vincent Fulginiti MD
    Sunir J. Garg MD, FACS
    Kevin J. Geary MD
    Lowell Goldsmith MD, MPH
    Sethuraman Gomathy MD
    Bernardo Gontijo MD, PhD
    Kenneth Greer MD
    Kenneth G. Gross MD
    Alan Gruber MD
    Nathan D. Gundacker MD
    Akshya Gupta MD
    Vidal Haddad MSC, PhD, MD
    Edward Halperin MD, MA
    Ronald Hansen MD
    John Harvey
    Rizwan Hassan MD
    Michael Hawke MD
    Jason E. Hawkes MD
    Peter W. Heald MD
    David G. Hicks MD
    Sarah Hocker DO
    Ryan J. Hoefen MD, PhD
    Li-Yang Hsu MD
    William Huang MD
    Sanjana Iyengar MD
    Alvin H. Jacobs MD
    Saagar Jadeja MD
    Shahbaz A. Janjua MD
    Joshua J. Jarvis MD
    Kit Johnson
    Zachary John Jones MD
    Robert Kalb MD
    A. Paul Kelly MD
    Henry Kempe MD
    Loren Ketai MD
    Sidney Klaus MD
    Ashwin Kosambia MD
    Jessica A. Kozel MD
    Carl Krucke
    Mario E. Lacouture MD
    Joseph Lam MD
    Alfred T. Lane MD
    Edith Lederman MD
    Nahyoung Grace Lee MD
    Pedro Legua MD, PhD
    Robert Levin MD
    Bethany Lewis MD
    Sue Lewis-Jones FRCP, FRCPCH
    Taisheng Li MD
    Christine Liang MD
    Shari Lipner MD, PhD
    Adam Lipworth MD
    Jason Maguire MD
    Mark Malek MD, MPH
    Jere Mammino DO
    Ricardo Mandojana MD
    Lynne Margesson MD
    Thomas J. Marrie MD
    Maydel Martinez MD
    Ralph Massey MD
    Patrick McCleskey MD
    Karen McKoy MD
    Thomas McMeekin MD
    Josette McMichael MD
    Somchai Meesiri MD
    Joseph F. Merola MD
    Mary Gail Mercurio MD
    Anis Miladi MD
    Larry E. Millikan MD
    Dan Milner Jr. MD
    Zaw Min MD
    Stephanie Montero
    Alastair Moore MD
    Keith Morley MD
    Dean Morrell MD
    Samuel Moschella MD
    Rehan Naseemuddin MD
    Taimor Nawaz MD
    Vic Newcomer MD
    John Nguyen MD
    Matilda Nicholas MD
    Thomas P. Nigra MD
    Steven Oberlender MD, PhD
    Maria Teresa Ochoa MD
    Art Papier MD
    Lawrence Parish MD
    Tanner Parrent MD
    Mukesh Patel MD
    Lauren Patty-Daskivich MD
    David Peng MD, MPH
    Robert Penne MD
    Nitipong Permpalung MD
    Miriam Pomeranz MD
    Doug Powell MD
    Harold S. Rabinovitz MD
    Christopher J. Rapuano MD
    Sireesha Reddy MD
    Angela Restrepo MD, PhD
    Bertrand Richert MD, PhD
    J. Martin Rodriguez, MD, FACP
    Theodore Rosen MD
    Misha Rosenbach MD
    Scott Schiffman MD
    Robert H. Schosser MD
    Glynis A. Scott MD
    Carlos Seas MD, MSc
    Deniz Seçkin MD
    Daniel Sexton MD
    Paul K. Shitabata MD
    Tor Shwayder MD, FAAP, FAAD
    Elaine Siegfried MD
    Gene Sienkiewicz MD
    Christye Sisson
    Philip I. Song MD
    Mary J. Spencer MD, FAAP
    Lawrence B. Stack MD
    Sarah Stein MD
    William Van Stoecker MD
    Frances J. Storrs MD
    Erik J. Stratman MD
    Lindsay C. Strowd MD
    Erika Summers MD
    Belinda Tan MD, PhD
    Robert Tomsick MD
    Hensin Tsao MD, PhD
    Richard P. Usatine MD
    Jenny Valverde MD
    Vishalakshi Viswanath MD
    Susan Voci MD
    Lisa Wallin ANP, FCCWS
    Douglas Walsh MD
    Ryan R. Walsh MD
    George Watt MD
    Clayton E. Wheeler MD
    Sally-Ann Whelan MS, NP, CWOCN
    Jan Willems MD, PhD
    James Henry Willig MD, MPH
    Karen Wiss MD
    Vivian Wong MD, PhD
    Sook-Bin Woo MS, DMD, MMSc
    Jamie Woodcock MD
    Stephen J. Xenias MD
    Nathaniel Yohannes
    Lisa Zaba MD
    Vijay Zawar MD
    Bonnnie Zhang MD
    Carolyn Ziemer MD
    Jeffrey P. Zwerner MD, PhD


Organizations

  • Am. Journal of Trop. Med & Hygiene
  • Armed Forces Pest Management Board
  • Blackwell Publishing
  • Bugwood Network
  • Centers For Disease Control and Prevention
  • Centro Internacional de Entrenamiento e Investigaciones Mèdicas (CIDEIM)
  • Dermatology Online Journal
  • East Carolina University (ECU), Division of Dermatology
  • International Atomic Energy Agency
  • Massachusetts Medical Society
  • Oxford University Press
  • Radiological Society of North America
  • Washington Hospital Center
  • Wikipedia
  • World Health Organization
ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferencesView all Images (12)
Neurofibromatosis - External and Internal Eye
See also in: Skin
Print
Other Resources UpToDate PubMed

Neurofibromatosis - External and Internal Eye

See also in: Skin
Print Images (12)
Contributors: Nitish Mehta MD, Lowell A. Goldsmith MD, MPH, Brandon D. Ayres MD, Christopher Rapuano MD, Harvey A. Brown MD, Sunir J. Garg MD, Lauren Patty Daskivich MD, MSHS
Other Resources UpToDate PubMed

Synopsis

Neurofibromatosis type 1 (NF1), or von Recklinghausen syndrome, and type 2 (NF2), or central neurofibromatosis, are multisystem genetic disorders arising from loss of function of the neurofibrin gene and subsequent unregulated cell division resulting in the formation of noncancerous tumors known as fibromas. Specifically, mutations of chromosome 17 (NF1) and 22 (NF2) cause loss of function of the tumor suppressor neurofibromin protein, resulting in inability to downregulate the Ras oncogene signal transduction pathway and subsequent continuous activation of antiapoptotic pathways. This summary will primarily cover the ophthalmologic manifestations of NF1 (eg, orbitofacial neurofibromas and optic nerve gliomas) in terms of diagnosis, management, and treatment recommendations.

NF1
Affecting 1 in 3000, NF1 is characterized by hallmark cutaneous, neurologic, bone, soft tissue, and ophthalmologic findings resulting from deregulated growth of neural crest origin cell lines.

Although 100% penetrant by age 5 years and though a third of affected patients will develop serious complications, NF1's diverse expression makes prognostic information difficult to deliver to patients. About 50% of the cases are familial, with an autosomal dominant expression pattern, and 50% of cases arise from de novo mutations.

Neurofibromatosis is clinically diagnosed via the presence of 2 or more of the following:
  • Six or more café-au-lait macules greater than 5 mm in prepubertal individuals and greater than 15 mm in diameter in postpubertal individuals
  • Two or more Lisch nodules (iris hamartomas)
  • Two or more neurofibromas of any type or a single plexiform neurofibroma
  • Freckling in the axillary or inguinal region (intertriginous)
  • Optic nerve glioma (in early childhood)
  • Distinctive osseus dysplasia (such as sphenoid or tibial)
  • A first-degree relative with NF1
Affected patients are often born with sphenoid wing dysplasia, long bone bowing, subclinical orbitofacial plexiform neurofibromas, and optic nerve gliomas, and at birth or early childhood develop multiple café-au-lait macules. In early childhood, patients will develop axillary / inguinal freckling, hypertension, and scoliosis. Patients will further progress to develop multiple cutaneous neurofibromas (peripheral nerve sheath tumors). Optic nerve gliomas and orbitofacial plexiform neurofibromas will slowly progress to become symptomatic by mid to late childhood.

Other malignancies and tumors associated with neurofibromatosis include pheochromocytomas, meningiomas, sarcomas, and gastrointestinal tumors of neuroendocrine origin. Patients may have learning disabilities (30%-50%), skeletal abnormalities, vasculopathies, and endocrinologic abnormalities.

Prompt ophthalmologic screening in patients with café-au-lait macules is recommended to diagnose NF1 and help prevent vision loss.
  • Optic nerve gliomas are grade 1 pilocytic astrocytomas in NF1 that affect the optic nerve, chiasm, or optic tract. They are the most common intraorbital or cranial manifestation of neurofibromatosis, affecting 30%-40% of patients. Often asymptomatic, they are slow growing, locally invasive, and can progress to produce significant morbidity though rarely mortality. Isolated asymptomatic optic nerve gliomas discovered during screening carry the best prognosis. Involvement of the chiasm, pulsatile proptosis, or extension along the visual pathway carries an unfavorable prognosis. Pulsatile proptosis, or the "Orphan Annie sign," is caused by absence of the sphenoid wing with a herniated encephalocele.
  • Orbitofacial plexiform neurofibromas are in seen in 1%-4% of children with NF1. These are variants of benign peripheral nerve sheath tumors that form tangles of unencapsulated, highly vascular, and infiltrative neural tissue involving the eyelids, temporal region, and orbit and causing physical disfiguration, asymmetric refractive error, and mechanical ptosis with a high incidence of resultant amblyopia. They may degenerate into malignant peripheral nerve sheath tumors such as neurofibrosarcomas. Plexiform neurofibromas of the upper eyelid can be associated with ipsilateral glaucoma.
NF2
NF2, or central neurofibromatosis, is 10 times less common than NF1 and primarily presents with acoustic neuromas (schwannomas of the 8th cranial nerve). NF2 presents with fewer café-au-lait macules, rarely forms Lisch nodules of the iris, and is primarily associated ophthalmologically with juvenile cataracts. Optic nerve meningiomas, retinal hamartomas, and epiretinal membranes are also associated with NF2, and any child with decreased vision or retinal exam abnormalities should undergo ophthalmologic evaluation to distinguish NF1 and NF2 from retinoblastoma.

Codes

ICD10CM:
Q85.01 – Neurofibromatosis, type 1
Q85.02 – Neurofibromatosis, type 2

SNOMEDCT:
19133005 – Neurofibromatosis syndrome

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

NF1
Other conditions with café-au-lait macules:
  • Legius syndrome – Autosomal dominant NF1-like syndrome with loss of function of Ras regulatory gene Spred1 with café-au-lait macules, axillary freckling, and macrocephaly but lacks neurofibromas and CNS tumors.
  • Constitutional mismatch repair-deficiency syndrome – Homozygous deficiency in 1 of the 4 mismatch repair proteins results in café-au-lait macules and axillary freckling but presents primarily with hematologic malignances in childhood followed by glioblastomas and colorectal cancer.
  • Noonan syndrome – Characterized by short stature, webbed neck, pulmonic stenosis, and café-au-lait macules without axillary freckling or Lisch nodules.
  • McCune-Albright syndrome – Premature puberty, bony abnormalities, and large café au lait macules with irregular outline.
The differential diagnosis for NF1 also includes:
NF2
The differential diagnosis for NF2 includes:

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Updated: 06/08/2016
Copyright © 2018 VisualDx®. All rights reserved.
Neurofibromatosis - External and Internal Eye
See also in: Skin
Print 12 Images
View all Images (12)
(with subscription)
Neurofibromatosis (Type 1 General Manifestations) : Lisch nodules, Axillary freckles, Smooth papules
Clinical image of Neurofibromatosis
Copyright © 2018 VisualDx®. All rights reserved.